Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Colgate-Palmolive Company (CL) vs KKR & Co Inc (KKR) Price & Performance

Colgate-Palmolive CompanyTrade
KKR & Co IncTrade

Price performance (Past 24H)

Key statistics

Colgate-Palmolive Company vs KKR & Co Inc — how do they compare? Colgate-Palmolive Company trades at $91.86 (market cap $73.59B), while KKR & Co Inc trades at $110.42 (market cap $99.61B). The key difference: KKR & Co Inc is the larger of the two by market cap, and Colgate-Palmolive Company pays the higher dividend (2.3%). Which is the better fit depends on your goals.

CLKKR
Market Cap
$73.59B$99.61B
Sector
Consumer StaplesFinancials
52-Week High
$99.14$149.34
52-Week Low
$74.98$83.88
Enterprise Value
$80.07B$22.17B
Dividend Yield
2.3%0.7%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Colgate-Palmolive Company

Colgate-Palmolive (CL) trades at $93.15, down 0.13% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported Q2 2026 EPS of $0.99, beating estimates, with 4.9% sales growth driven by emerging markets. However, North American weakness persists, and valuation ratios like P/E of 36.34 and P/B of 311.81 appear elevated. Cash flow remains positive, and a dividend of $0.53 is scheduled for August 2026.

Outlook is mixed: strong brand presence and dividend sustainability support the stock, but high valuation and domestic challenges pose risks. Analyst consensus price target is $99.10, implying modest upside, with 42% buy ratings. Key risks include competitive pressures and margin compression from inflation.

KKR & Co Inc

KKR trades at $103.83, up 0.99% with strong bullish momentum. The stock shows robust earnings performance with Q2 2026 EPS of $1.63 beating estimates of $1.43, continuing a trend of positive surprises. Recent acquisitions including Integer Holdings ($4.3B) and Medicover India ($1.39B) demonstrate aggressive growth strategy. Analyst consensus remains overwhelmingly bullish with 24 buy ratings and $127.22 price target, representing 22.5% upside potential from current levels.

KKR presents compelling investment opportunity with strong fundamentals, consistent earnings beats, and strategic acquisitions driving growth. Key risks include integration challenges from recent deals, market volatility affecting asset management fees, and potential regulatory scrutiny of private equity operations. The company's $19.2B infrastructure fund closure signals strong institutional confidence in long-term strategy.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Colgate-Palmolive Company

Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.

Read more on CL

About KKR & Co Inc

KKR is one of the world's largest alternative asset managers, with $490.7 billion in total assets under management, including $384.5 billion in fee-earning AUM, at the end of June 2022. The company has two core segments: asset management (which includes private markets--private equity, credit, infrastructure, energy and real estate--and public markets--primarily credit and hedge/investment fund platforms) and insurance (following the February 2021 purchase of a 61.5% economic stake in Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance). On the asset management side, private markets account for 50% of fee-earning AUM and 70% of base management fees, while public markets account for 50% and 30%, respectively.

Read more on KKR